Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
[Semaphorin 4 in multiple sclerosis].
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders?
Cell surface levels of endothelial ICAM-1 influence thetranscellular or paracellularT-celldiapedesis across the blood-brain barrier.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Changes of Synaptic Plasticity in Multiple Sclerosis.
Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation.
condition Specific Utilities: Impact on Icer in a Markov Model for Multiple Sclerosis.
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
P2X4 receptors control the fate and survival of activated microglia.
Voiding Dysfunction in Multiple Sclerosis.
Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their health.
[Animal model of neuromyelitis optica].
Callosal anatomical and effective connectivity between primary motor cortices predicts visually cued bimanual temporal coordination performance.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Potential pathogens in multiple sclerosis (MS.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Symptoms of multiple sclerosis during use of combined hormonal contraception.
HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »